Adherence to aromatase inhibitors (AIs) in Hispanic patients with early stage breast cancer

被引：2
|
作者：
Philipovskiy, Alexander
Campbell, Aleli
Heydarian, Rosalinda
Lin, Krysta
Nahleh, Zeina A.
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, El Paso, TX USA
[2] Univ Texas El Paso, El Paso, TX 79968 USA
[3] Cleveland Clin Florida, Weston, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 07期
关键词：
D O I：
10.1200/JCO.2018.36.7_suppl.70
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
70
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PHARMACOGENETICS OF AROMATASE INHIBITORS (AIS) IN PATIENTS WITH METASTATIC BREAST CANCER
    Ferraldeschi, R.
    Arnedos, M.
    Hadfield, K.
    Ahern, R.
    Drury, S.
    Roberts, S.
    Howell, A.
    Smith, I.
    Newman, W.
    Dowsett, M.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 60 - 60
  • [2] Early discontinuation of tamoxifen and aromatase inhibitors (AIs) by postmenopausal women with early-stage breast cancer.
    Charlson, J. A.
    Hedin, T.
    Sparapani, R.
    Guo, C.
    Nattinger, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Adherence to guidelines for bone health in a predominantly Hispanic cohort of breast cancer patients receiving aromatase inhibitors
    Bright, Tamis M.
    Mcalice, Meghan K.
    Escriba-Omar, Abelardo
    Gaur, Sumit
    Philipovskiy, Alexander V.
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [4] Aromatase inhibitors as adjuvant therapy for postmenopausal patients with early stage breast cancer
    Kudchadkar, R
    O'Regan, RM
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (03) : 145 - 163
  • [5] Aromatase inhibitors and calcium absorption in early stage breast cancer
    Amye Tevaarwerk
    Mark E. Burkard
    Kari B. Wisinski
    Martin M. Shafer
    Lisa A. Davis
    Jyothi Gogineni
    Elizabeth Crone
    Karen E. Hansen
    [J]. Breast Cancer Research and Treatment, 2012, 134 : 245 - 251
  • [6] Aromatase inhibitors and calcium absorption in early stage breast cancer
    Tevaarwerk, Amye
    Burkard, Mark E.
    Wisinski, Kari B.
    Shafer, Martin M.
    Davis, Lisa A.
    Gogineni, Jyothi
    Crone, Elizabeth
    Hansen, Karen E.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 245 - 251
  • [7] Update on the use of aromatase inhibitors in early-stage breast cancer
    Kesisis, Georgios
    Makris, Andreas
    Miles, David
    [J]. BREAST CANCER RESEARCH, 2009, 11 (05)
  • [8] Aromatase inhibitors and other agents in early-stage breast cancer
    Goss, PE
    Strasser-Weippi, K
    [J]. ADVANCES IN ENDOCRINE THERAPY OF BREAST CANCER, PROCEEDINGS, 2004, : 55 - 71
  • [9] Update on the use of aromatase inhibitors in early-stage breast cancer
    Georgios Kesisis
    Andreas Makris
    David Miles
    [J]. Breast Cancer Research, 11
  • [10] Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors
    Henry, N. Lynn
    Giles, Jon T.
    Ang, Dennis
    Mohan, Monika
    Dadabhoy, Dina
    Robarge, Jason
    Hayden, Jill
    Lemler, Suzanne
    Shahverdi, Karineh
    Powers, Penny
    Li, Lang
    Flockhart, David
    Stearns, Vered
    Hayes, Daniel F.
    Storniolo, Anna Maria
    Clauw, Daniel J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 111 (02) : 365 - 372
12345